CFRA Research has raised its S&P 500 year-end target to 6,525 and its 12-month forecast to 6,850, citing a strong market ...

CFRA’s 12-month price target of $392 on the stock reflects a 13.2x multiple of 2025 EPS, slightly above Cigna’s five-year average, justified by “balance sheet improvement, pharmaceutical business ...

Investing.com -- Cigna Group is contending with elevated industry-wide medical costs that are expected to weigh on its Healthcare segment in 2025, according to CFRA, which downgraded the stock to ...

However, CFRA's decision to lower their rating comes as the 2025 margin guidance did not meet their initial expectations. The analyst also provided updated earnings per share (EPS) estimates for ...

On Thursday, CFRA research firm upgraded 3M (NYSE: MMM) stock, which is listed on the NYSE:MMM, from a Buy to a Strong Buy status, establishing a price target of $165.00. The upgrade comes as CFRA ...

On Thursday, CFRA research firm upgraded 3M stock, which is listed on the NYSE:MMM, from a Buy to a Strong Buy status, establishing a price target of $165.00. The upgrade comes as CFRA analyst ...

CFRA analyst Zachary Warring discusses Nike's latest results, and the tough road ahead laid out by new CEO Elliott Hill to turn the business around.

CFRA expects banks to outperform the broader S&P 500 index (SP500) next year, citing growth prospects and Trump's second term. Read more here.

CFRA's Sam Stovall begins by discussing the three primary forces driving equities in Q3 and Q4 – Chinese stimulus, fading inflation pressures, and Fed rate cuts.

These factors have led to a more cautious stance by CFRA. Despite the downgrade, CFRA maintains its FY 25 EPS estimate for Super Micro Computer at $32.82 and FY 26's estimate at $44.34.